These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 28572692)

  • 1. Joint coverage probability in a simulation study on Continuous-Time Markov Chain parameter estimation.
    Benoit JS; Chan W; Doody RS
    J Appl Stat; 2015; 42(12):2531-2538. PubMed ID: 28572692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hidden Markov model approach to analyze longitudinal ternary outcomes when some observed states are possibly misclassified.
    Benoit JS; Chan W; Luo S; Yeh HW; Doody R
    Stat Med; 2016 Apr; 35(9):1549-57. PubMed ID: 26782946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A joint logistic regression and covariate-adjusted continuous-time Markov chain model.
    Rubin ML; Chan W; Yamal JM; Robertson CS
    Stat Med; 2017 Dec; 36(28):4570-4582. PubMed ID: 28695582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-homogeneous continuous-time Markov chain with covariates: Applications to ambulatory hypertension monitoring.
    Chang J; Chan HK; Lin J; Chan W
    Stat Med; 2023 May; 42(12):1965-1980. PubMed ID: 36896833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bias correction of two-state latent Markov process parameter estimates under misclassification.
    Rosychuk RJ; Thompson ME
    Stat Med; 2003 Jun; 22(12):2035-55. PubMed ID: 12802821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian restoration of ion channel records using hidden Markov models.
    Rosales R; Stark JA; Fitzgerald WJ; Hladky SB
    Biophys J; 2001 Mar; 80(3):1088-103. PubMed ID: 11222275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpretation of simulation studies for efficient estimation of population pharmacokinetic parameters.
    Ette EI; Kelman AW; Howie CA; Whiting B
    Ann Pharmacother; 1993 Sep; 27(9):1034-9. PubMed ID: 8117353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal clinical trial design based on a dichotomous Markov-chain mixed-effect sleep model.
    Steven Ernest C; Nyberg J; Karlsson MO; Hooker AC
    J Pharmacokinet Pharmacodyn; 2014 Dec; 41(6):639-54. PubMed ID: 25308776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of variance estimation approaches in a two-state Markov model for longitudinal data with misclassification.
    Rosychuk RJ; Sheng X; Stuber JL
    Stat Med; 2006 Jun; 25(11):1906-21. PubMed ID: 16220512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of estimation, prediction and inference for autocorrelated latent variable modeling of binary data-a simulation study.
    Hutmacher MM
    J Pharmacokinet Pharmacodyn; 2016 Jun; 43(3):275-89. PubMed ID: 27007275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive moment closure for parameter inference of biochemical reaction networks.
    Schilling C; Bogomolov S; Henzinger TA; Podelski A; Ruess J
    Biosystems; 2016 Nov; 149():15-25. PubMed ID: 27461396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition probability estimates for non-Markov multi-state models.
    Titman AC
    Biometrics; 2015 Dec; 71(4):1034-41. PubMed ID: 26148652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of transtheoretical model of health behavioral changes in a nutrition intervention study--a continuous time Markov chain model with Bayesian approach.
    Ma J; Chan W; Tsai CL; Xiong M; Tilley BC
    Stat Med; 2015 Nov; 34(27):3577-89. PubMed ID: 26123093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A gradient Markov chain Monte Carlo algorithm for computing multivariate maximum likelihood estimates and posterior distributions: mixture dose-response assessment.
    Li R; Englehardt JD; Li X
    Risk Anal; 2012 Feb; 32(2):345-59. PubMed ID: 21906114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-varying Markov regression random-effect model with Bayesian estimation procedures: Application to dynamics of functional recovery in patients with stroke.
    Pan SL; Chen HH
    Math Biosci; 2010 Sep; 227(1):72-9. PubMed ID: 20600158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient Learning of Continuous-Time Hidden Markov Models for Disease Progression.
    Liu YY; Li S; Li F; Song L; Rehg JM
    Adv Neural Inf Process Syst; 2015; 28():3599-3607. PubMed ID: 27019571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Part 2. Development of Enhanced Statistical Methods for Assessing Health Effects Associated with an Unknown Number of Major Sources of Multiple Air Pollutants.
    Park ES; Symanski E; Han D; Spiegelman C
    Res Rep Health Eff Inst; 2015 Jun; (183 Pt 1-2):51-113. PubMed ID: 26333239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling multivariate discrete failure time data.
    Shih JH
    Biometrics; 1998 Sep; 54(3):1115-28. PubMed ID: 9750256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bias in Markov models of disease.
    Faissol DM; Griffin PM; Swann JL
    Math Biosci; 2009 Aug; 220(2):143-56. PubMed ID: 19538974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Bayesian method for construction of Markov models to describe dynamics on various time-scales.
    Rains EK; Andersen HC
    J Chem Phys; 2010 Oct; 133(14):144113. PubMed ID: 20949993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.